Predictors and importance of prolonged hospital stay after primary PCI for ST elevation myocardial infarction

Coronary Artery Disease

Volumn 22, Issue 7, 2011, Pages 458-462

  Schellings, Dirk A A M ^a   Ottervanger, Jan Paul ^a   Van'T Hof, Arnoud W J ^a   De Boer, Menko Jan ^a   Dambrink, Jan Henk E ^a   Hoorntje, Jan C A ^a   Gosselink And, Marcel ^a   Suryapranata, Harry ^a  

^a Isala Klinieken ^*  (Netherlands)

Author keywords

hospital duration; myocardial infarction; percutaneous coronary intervention; prognosis

Indexed keywords

ADULT; ARTICLE; BLOOD CLOT LYSIS; FEMALE; GROUPS BY AGE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY CIRCULATION; FEMALE; HEART FAILURE; HOSPITALS; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NETHERLANDS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 80053630137     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283495d5f     Document Type: Article

References (21)

1. Spencer FA, Lessard D, Gore JM, Yarzebski J, Goldberg RJ. Declining length of hospital stay for acute myocardial infarction and post discharge outcome. Arch Intern Med 2004; 164:733-740. (Pubitemid 38478695)
2. Newby LK, Califf RM, Guerci A,Weaver WD, Col J, Horgan JH, et al.; for the GUSTO investigators. Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the global utilization of streptokinase and t-PA for occluded coronary arteries (GUSTO) trial. J Am Coll Cardiol 1996; 27:625-632. (Pubitemid 26081921)
3. Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26:804-847.
4. Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, et al. 2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 2009; 120:2271-2306.
5. Grines CL, Marsalese DL, Brodie B, Griffin J, Donohue B, Costantini CR, et al.; for the PAMI-II investigators. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. J Am Coll Cardiol 1998; 5:967-972. (Pubitemid 28212494)
6. Halkin A, Singh M, Nikolsky E, Grines CL, Tcheng JE, Garcia E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 2005; 45:1397-1405. (Pubitemid 40615609)
7. De Luca G, Suryapranata H, van 't Hof AWJ, De Boer MJ, Hoorntje JCA, Dambrink JHE, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation 2004; 109:2737-2743. (Pubitemid 38737921)
8. Heggunje PS, Harjai KJ, Stone GW, Mehta RH, Marsalese DL, Boura JA, et al. Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44:1400-1407. (Pubitemid 39303940)
9. Jirmar R, Widimsky P, Capek J, Hlinomaz O, Groch L. Next day discharge after successful primary angioplasty for acute ST elevation myocardial infarction. Int Heart J 2008; 49:653-659.
10. Branca G, Capodanno D, Capranzano P, Barbagallo R, Seminara D, Licciardello G, et al. Early discharge in acute myocardial infarction after clinical and angiographic risk assessment. J Cardiovasc Med 2008; 9: 858-861.
11. Kotowycz MA, Cosman TL, Tartaglia C, Afzal R, Pal Syal R, Natarajan MK. Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction. A prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the SAFE-Depart Trial). Am Heart J 2010; 159:117e1-117e6.
12. Laarman GJ, Dirksen M. Early discharge after primary percutaneous coronary intervention. Heart 2010; 96:584-587.
13. Henriques JPS, Zijlstra F, van 't Hof AWJ, De Boer MJ, Dambrink JHE, Gosselink ATM, et al. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 2003; 107:2115-2119. (Pubitemid 36532193)
14. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendation for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee of Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
15. van 't Hof AWJ, Ten Berg J, Heestermans T, Dill T, Funck RC, Van Werkum W, et al.; on behalf of the ongoing tirofiban in myocardial infarction evaluation (On-Time) 2 study group. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-Time 2): a multicentre, double-blind, randomised controlled trial. Lancet 2008; 372:537-546.
16. Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KAA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006; 114:774-782. (Pubitemid 44268228)
17. Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Dangas GD, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol 2007; 49:1362-1368. (Pubitemid 46476844)
18. Mehran R, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, et al. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet 2009; 374:1149-1159.
19. Dambrink JHE, Debrauwere JP, van 't Hof AWJ, Ottervanger JP, Gosselink ATM, Hoorntje JCA, et al. Non culprit lesions detected during primary PCI: treat invasively or follow the guidelines? Eurointervention 2010; 8:968-975.
20. Ottervanger JP, Ramdat Misier AR, Dambrink JHE, De Boer MJ, Hoorntje JCA, Gosselink ATM, et al.; on behalf of the Zwolle myocardial infarction study group. Mortality in patients with left ventricular ejection fraction 30% after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol 2007; 100:793-797. (Pubitemid 47268271)
21. Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD; for the platelet receptor inhibition in ischemic syndrome management (PRISM) investigators. N-Terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004; 110:3206-3212. (Pubitemid 39525067)